The goal of this research is to increase out understanding of the mechanisms of the ATP-dependent proteolytic enzymes that catalyze the degradation of most proteins in bacterial and eukaryotic cells. These novel enzymes are all large multimeric complexes that cleave proteins in ATP linked reactions. In eukaryotic cells, the major site for protein breakdown is the 20S proteasome, which also generates peptides used in MHC-class I antigen presentation. Unlike conventional proteases, these enzymes degrade proteins completely to peptides before attacking the next substrate molecule. This research will provide understanding of this processive mechanism and determine what factors influence the size and number of peptides generated, and indicate whether the proteases proceed along the substrate in a specific direction. These studies will employ the 20S particles from archaebacteria and mammalian cells, including the modified form of the proteasome (i.e., the """"""""immunoproteasomes"""""""") induced by gamma-interferon. The 20S particle serves as the proteolytic core of the 26S proteasome complex, which degrades ubiquitin-conjugated proteins. This complex also contains six different ATPases, and a major goal will be to clarify their functions in protein degradation. Recently a new type of ATP-dependent protease complex (HslU/HslV) from E. coli has been isolated that has homologies to eukaryotic proteasome. The research will elucidate its structure, to clarify how the HslU-ATPase subunits regulate the activity of the HslV peptidase, and to learn if similar complexes are present in other cells or organelles. Finally, the project will explore the processive mechanism of the model ATP-dependent protease, La (lon), which catalyzes the rapid degradation of abnormal proteins in E. coli and mitochondria.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM046147-08
Application #
6018842
Study Section
Biochemistry Study Section (BIO)
Project Start
1992-09-30
Project End
2000-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
8
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Harvard University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Kisselev, Alexei F; van der Linden, Wouter A; Overkleeft, Herman S (2012) Proteasome inhibitors: an expanding army attacking a unique target. Chem Biol 19:99-115
Qiu, Xiao-Bo; Ouyang, Song-Ying; Li, Chao-Jun et al. (2006) hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. EMBO J 25:5742-53
Lecker, Stewart H; Goldberg, Alfred L; Mitch, William E (2006) Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17:1807-19
Kisselev, Alexei F; Callard, Alice; Goldberg, Alfred L (2006) Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem 281:8582-90
Cascio, Paolo; Goldberg, Alfred L (2005) Preparation of hybrid (19S-20S-PA28) proteasome complexes and analysis of peptides generated during protein degradation. Methods Enzymol 398:336-52
Chang, Shih-Chung; Momburg, Frank; Bhutani, Nidhi et al. (2005) The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a ""molecular ruler"" mechanism. Proc Natl Acad Sci U S A 102:17107-12
Brignone, Chrystelle; Bradley, Kathleen E; Kisselev, Alexei F et al. (2004) A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway. Oncogene 23:4121-9
Kisselev, Alexei F; Garcia-Calvo, Margarita; Overkleeft, Herman S et al. (2003) The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites. J Biol Chem 278:35869-77
Benaroudj, Nadia; Zwickl, Peter; Seemuller, Erika et al. (2003) ATP hydrolysis by the proteasome regulatory complex PAN serves multiple functions in protein degradation. Mol Cell 11:69-78
Huang, H C; Sherman, M Y; Kandror, O et al. (2001) The molecular chaperone DnaJ is required for the degradation of a soluble abnormal protein in Escherichia coli. J Biol Chem 276:3920-8

Showing the most recent 10 out of 28 publications